Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

House dust mite allergy immunotherapy - Bial

Next Previous
X
Search
Drug Profile

House dust mite allergy immunotherapy - Bial

Alternative Names: 1-day polymerized depot Allergovac; Allergovac DPT; Allergovac house dust mite; Allergovac house dust mite depot; BIA 15-2957; Polymerized depot allergovac - Bial; V01AA

Latest Information Update: 02 Oct 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bial
  • Developer BIAL
  • Class Allergens; Allergy immunotherapies; Antiallergics
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Allergic rhinoconjunctivitis

Most Recent Events

  • 01 Sep 2017 Roxall Medicina Espana completes a phase I trial for Allergic rhinoconjunctivitis in Spain (SC) (NCT02881879)
  • 10 Apr 2017 Bial Industrial Farmacéutica terminates phase II trial in Allergic rhinoconjunctivitis in Spain (EudraCT2016-002944-18)
  • 14 Nov 2016 BIAL Industrial Farmaceutca initiates a phase II trial for Allergic rhinoconjunctivitis in Spain (EudraCT2016-002944-18)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top